Most Popular
|
Research Trends
|
| Advancing Cystic Fibrosis Research with the Novel CFTR*F508del Humanized Disease Model |
| Jan 17, 2025 |
| Cystic fibrosis (CF) remains a devastating genetic disease, affecting tens of thousands worldwide with no cure in sight. Read More > |
|
Research Trends
|
| High-Efficiency B Cell Research with the Improved Mb1-iCre Mouse Model |
| Jan 09, 2025 |
| In immunology, B cells are a crucial component of the adaptive immune system. To better understand their function, scientists have developed specialized research tools and models. Read More > |
|
Research Trends
|
| A Mouse Model for Researching Intestinal Disorders & Paneth Cells: Lyz1-H2BmCherry-IRES-CreERT2 Mice |
| Jan 03, 2025 |
| Are you looking for cutting-edge tools to advance your research on intestinal immunity and inflammatory bowel diseases (IBD)? Read More > |
|
Research Trends
|
| Revolutionizing Neurological Disease Research with Cyagen's Mouse Models |
| Dec 27, 2024 |
| Neurological diseases, such as Alzheimer’s disease, Parkinson’s disease, and epilepsy, remain some of the most challenging areas of research in biomedical science. Read More > |
|
Research Trends
|
| How the ABCA4 Gene Model Supports Research Breakthroughs in Gene Therapy Drug Development |
| Dec 20, 2024 |
| Gene editing and RNA therapies are reshaping the future of medicine, with recent breakthroughs making headlines worldwide. Read More > |
|
Research Trends
|
| Entry Tips for the HUGO-GT™ Grant Awards: Get Funds for Humanized Mouse Models |
| Dec 13, 2024 |
| The HUGO-GT™ Grant Awards aim to support impactful preclinical research projects by providing researchers access to state-of-the-art humanized mouse models. Read More > |
|
Research Trends
|
| JAK2V617F Mutant Mouse Model: A Robust Tool for Myeloproliferative Neoplasm Research |
| Dec 06, 2024 |
| Are you looking to advance your understanding of myeloproliferative neoplasms (MPNs) and their genetic underpinnings? Read More > |
|
Research Trends
|
| VEGFA Humanized and Transgenic Mice: Empowering Ophthalmology & Oncology Drug Development |
| Nov 29, 2024 |
| How do we bridge the gap between preclinical research and breakthrough therapies for retinal diseases and cancer? Read More > |
|
Research Trends
|
| Humanized Tau Protein Mouse Models to Accelerate Alzheimer's Drug Development |
| Nov 22, 2024 |
| Alzheimer’s disease (AD) drug development continues to face challenges in 2024, with recent failures highlighting the need for new approaches targeting Tau protein. Read More > |
|
Newsletter
Breaking News
|
| Cyagen and Lumiere Therapeutics Forge Strategic Partnership to Advance Commercialization of the enCas12Ultra Base Editing System |
| Nov 18, 2024 |
| Recently, Cyagen (Suzhou) Biosciences Co., Ltd. ("Cyagen") signed a strategic cooperation agreement with Lumiere Therapeutics (Suzhou) Co., Ltd. ("Lumiere") to jointly advance the commercialization of Lumiere’s enCas12Ultra. Read More > |
